DoW Traumatic Brain Injury and Psychological Health, Translational Research Award

The Traumatic Brain Injury and Psychological Health Translational Research Award is offered through the Defense Health Agency under the Congressionally Directed Medical Research Programs as part of the Traumatic Brain Injury and Psychological Health Research Program. This program was established to address the significant impact of traumatic brain injuries and psychological health conditions experienced by military service members and has received substantial congressional appropriations since its inception. The Translational Research Award specifically focuses on advancing research that moves scientific discoveries into practical clinical applications that can improve patient care, outcomes, and overall health system effectiveness for both military and civilian populations. The purpose of this funding opportunity is to accelerate the translation of promising scientific findings into tangible healthcare solutions such as clinical tools, technologies, or evidence-based practices. The program prioritizes innovative, non-incremental research that demonstrates the potential to significantly improve clinical care or patient outcomes. Applications proposing only minor refinements to existing approaches are not considered responsive. Research supported under this award must align with one of three major focus areas: understanding the underlying causes and risk factors of traumatic brain injury or psychological health conditions, preventing and assessing these conditions, or developing treatments and interventions to improve outcomes. Funding is available across two research levels. Research Level 1 supports the refinement of mature concepts into products or knowledge outputs ready for further evaluation, while Research Level 2 supports rigorous evaluation in preparation for first-in-human studies or clinical trials. Maximum funding is capped at one million dollars for Level 1 and two million dollars for Level 2, with a maximum performance period of four years. The program anticipates awarding approximately six grants in total. Clinical trials and basic research are explicitly prohibited, and applicants must provide preliminary data to support their proposed work. Additional requirements include the use of community-based participatory research approaches for studies involving prospective human subjects and adherence to data sharing and research rigor standards. Eligibility for this opportunity is broad and includes domestic and international organizations, both for-profit and nonprofit, as well as public and private entities. Principal investigators must be independent researchers affiliated with an eligible organization. An optional Early-Career Investigator Partnering Option allows for collaboration between two principal investigators, one of whom must be within ten years of completing their terminal degree. Applications must be submitted by organizations rather than individuals, and investigators may not be listed on more than four applications under this mechanism. The application process follows a two-step submission structure. Applicants must first submit a pre-application through the Electronic Biomedical Research Application Portal, which includes a concise narrative outlining the project’s focus, rationale, and innovation. Selected applicants are then invited to submit a full application through either eBRAP or Grants.gov, depending on organizational type. The full application requires extensive documentation including a project narrative, technical and lay abstracts, statement of work, impact statement, and additional supporting materials. Review occurs in two stages: peer review to assess scientific merit and programmatic review to evaluate alignment with program priorities and overall impact. Evaluation criteria emphasize the potential impact of the research, the strength of the study design, feasibility, and the qualifications of the research team. Additional considerations include plans for transitioning research outcomes into clinical use or commercialization and strategies for data sharing. Applications involving human subjects must include detailed recruitment and safety plans, and those involving animals must include comprehensive animal research protocols. The program also requires strict adherence to regulatory and ethical standards, including data sharing policies and research transparency guidelines. Key deadlines include a pre-application submission deadline of July 13, 2026, followed by an invitation decision in August 2026. Full applications are due October 15, 2026, with peer review expected in December 2026 and programmatic review in March 2027. Awards are anticipated to be issued no later than September 30, 2027. Applicants are required to maintain active registrations in federal systems such as SAM.gov and Grants.gov and are encouraged to begin the application process early due to the complexity and administrative requirements involved.

Focus on non-incremental innovation and strong preliminary data; clearly demonstrate translational impact and alignment with program focus areas; ensure compliance with CBPR and data sharing requirements